FDA Approves First Generic Ondansetron Tablets, Orally Disintegrating Tablets and Oral Solution
The Food and Drug Administration today approved the first generic versions of Zofran (Ondansetron) Tablets, Orally Disintegrating Tablets and Oral Solution which are indicated to prevent nausea and vomiting associated with surgery, radiotherapy and cancer chemotherapy.